Repro Med Systems, Inc. (KRMD)
| Previous Close | 2.1000 |
| Open | 2.0500 |
| Bid | 1.0000 x 1000 |
| Ask | 3.0000 x 1100 |
| Day's Range | 2.0000 - 2.1900 |
| 52 Week Range | 1.9000 - 4.8300 |
| Volume | |
| Avg. Volume | 42,504 |
| Market Cap | 96.252M |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
KORU Medical Systems Announces 2022 First Quarter Financial Results
CHESTER, N.Y., May 04, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the first quarter ended March 31, 2022.
- Business Wire
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®
CHESTER, N.Y., May 02, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion system to deliver pegcetacoplan 20 mL solution, branded as EMPAVELI® or Aspaveli® and c
- Business Wire
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
CHESTER, N.Y., April 20, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report first quarter 2022 financial results on Wednesday, May 4, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corp
